Disclosed herein are microbial defense systems, which provide cells protection against phage infection and plasmid transformation. Methods of use of these defense systems for protecting cells from phage infection and plasmid transformation are also disclosed, wherein defense systems may be used individually or in combination. In addition, disclosed herein are methods of making cells that express these defense systems.

The invention pertains to a composition for use in (a) treatment of impaired motor skills in a mammal suffering from Parkinson's Disease; (b) improving the efficacy of levodopa (L-DOPA) in treatment of impaired motor skills in a mammal suffering from Parkinson's Disease; and/or (c) reducing L-DOPA associated side effects, preferably involuntary movements selected from the group consisting of choreiform, dystonic and dyskinetic movements, in the treatment of impaired motor skills in a mammal suffering from Parkinson's Disease, comprising co-administering to the subject L-DOPA and a composition comprising therapeutically effective amounts of: (i) at least one of uridine, cytidine, or salts, phosphates, acyl derivatives or esters thereof; (ii) at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA); (iii) choline, or salts or esters thereof; and (iv) at least one vitamin B selected from vitamins B6, B9 and B12.

The present invention relates to a low-density lipoprotein (LDL)-cholesterol-lowering preparation, in particular to a bacterial cell extract for use as a medicament for lowering of the blood plasma LDL-cholesterol level, wherein the extract is obtained by extraction for between 10 minutes and 48 hours at between 8 C. and 37 C., while mixing the cells with the mixture, and wherein the ldl-cholesterol-lowering cell extract and food supplementldl-cholesterol-lowering cell extract and food supplement Rhodospirillum rubrum cells are extracted with the mixture in a volume ratio of between 10:1 and 1:10 of petroleum ether with a boiling point of between 60 C. and 80 C. and methanol comprising sodium chloride. More specifically, the present invention relates to a petroleum ether extract of Rhodospirillum rubrum obtainable by extraction of Rhodospirillum rubrum cells with a mixture of petroleum ether with a boiling point of between 60 C. and 80 C. and methanol comprising sodium chloride. The invention also relates to the petroleum ether extract of Rhodospirillum rubrum of the invention, for use in a method for the lowering of LDL-cholesterol in blood plasma of a subject. The invention further relates to a pharmaceutical preparation, a food supplement containing said preparation, a foodstuff containing said food supplement, and to a method for their preparation.

Provided herein are methods and compositions for synthesizing 5Capped RNAs wherein the initiating capped oligonucleotide primers have the general form .sup.m7 Gppp[N.sub.2Ome].sub.n[N].sub.m wherein .sup.m7G is N7-methylated guanosine or any guanosine analog, N is any natural, modified or unnatural nucleoside, n can be any integer from 0 to 4 and m can be an integer from 1 to 9.

Provided herein are methods and compositions for synthesizing 5Capped RNAs wherein the initiating capped oligonucleotide primers have the general form .sup.m7 Gppp[N.sub.2Ome].sub.n[N].sub.m wherein .sup.m7G is N7-methylated guanosine or any guanosine analog, N is any natural, modified or unnatural nucleoside, n can be any integer from 0 to 4 and m can be an integer from 1 to 9.

The present invention provides methods and compositions for balancing electron reduction potentials of formulations in a manner that reduces susceptibility to changes from xenobiotics. The present invention also provides novel compositions of matter based on structuring from a mobile nucleotide integral to its architecture.

The present invention provides methods and compositions for balancing electron reduction potentials of formulations in a manner that reduces susceptibility to changes from xenobiotics. The present invention also provides novel compositions of matter based on structuring from a mobile nucleotide integral to its architecture.

Preparation method and application of astaxanthin H1-, or H2- or J-aggregate water dispersion system are provided. The three kind of color-different astaxanthin multimer nano-dispersion systems utilize a special molecular structure of natural biomacromolecule chitosan and fish sperm DNA as well as physical interaction between macromolecules to induce formation and stability of astaxanthin multimers under solvent and salt ion-effects. Low-toxicity ethanol is selected as a good solvent for astaxanthin. The organic solvent can be completely removed in the later stage of the preparation process, and can be further enriched and recycled, which is beneficial to clean production and low cost. By adjusting process parameters, the H1-, or H2- or J-type astaxanthin aggregate water dispersion system can be obtained, so as to control a coloration range of astaxanthin water-based products to be yellow, orange and pink. Furthermore, during concentration, dehydration and reconstitution, astaxanthin aggregation patterns and coloring effects are maintained.

Provided herein are methods and compositions for synthesizing 5Capped RNAs wherein the initiating capped oligonucleotide primers have the general form .sup.m7Gppp[N.sub.2Ome].sub.n[N].sub.m wherein .sup.m7G is N7-methylated guanosine or any guanosine analog, N is any natural, modified or unnatural nucleoside, n can be any integer from 0 to 4 and m can be an integer from 1 to 9.

Provided herein are methods and compositions for synthesizing 5Capped RNAs wherein the initiating capped oligonucleotide primers have the general form .sup.m7Gppp[N.sub.2Ome].sub.n[N].sub.m wherein .sup.m7G is N7-methylated guanosine or any guanosine analog, N is any natural, modified or unnatural nucleoside, n can be any integer from 0 to 4 and m can be an integer from 1 to 9.